Search

Your search keyword '"Schrag, Anette"' showing total 1,222 results
Start Over Author "Schrag, Anette"
1,222 results on '"Schrag, Anette"'

106. 101 Motor and non-motor features of prodromal PD

Author

Rees, Richard, primary, Simonet, Cristina, additional, Gill, Aneet, additional, Giovannoni, Gavin, additional, Bestwick, Jonathan, additional, Lees, Andrew, additional, Noyce, Alastair, additional, and Schrag, Anette, additional

Published
2022
Full Text
View/download PDF

111. The natural history of multiple system atrophy: a prospective European cohort study

Author

Wenning, Gregor K, Geser, Felix, Krismer, Florian, Seppi, Klaus, Duerr, Susanne, Boesch, Sylvia, Köllensperger, Martin, Goebel, Georg, Pfeiffer, Karl P, Barone, Paolo, Pellecchia, Maria Teresa, Quinn, Niall P, Koukouni, Vasiliki, Fowler, Clare J, Schrag, Anette, Mathias, Christopher J, Giladi, Nir, Gurevich, Tanya, Dupont, Erik, Ostergaard, Karen, Nilsson, Christer F, Widner, Håkan, Oertel, Wolfgang, Eggert, Karla Maria, Albanese, Alberto, del Sorbo, Francesca, Tolosa, Eduardo, Cardozo, Adriana, Deuschl, Günther, Hellriegel, Helge, Klockgether, Thomas, Dodel, Richard, Sampaio, Cristina, Coelho, Miguel, Djaldetti, Ruth, Melamed, Eldad, Gasser, Thomas, Kamm, Christoph, Meco, Giuseppe, Colosimo, Carlo, Rascol, Olivier, Meissner, Wassilios G, Tison, François, and Poewe, Werner

Published
2013
Full Text
View/download PDF

113. EAN/MDS-ES guideline on the treatment of Parkinson’s Disease: I. Invasive therapies

Author

Deuschl, Günther, Antonini, Angelo, Costa, João, Śmiłowska, Katarzyna, Berg, Daniela, Corvol, Jean Christophe, Fabbrini, Giovanni, Ferreira, Joaquim, Foltynie, Tom, Mir, Pablo, Schrag, Anette-Eleonore, Seppi, Klaus, Taba, Pille, Ruzicka, Evzen, Selikhova, Marianna, Henschke, Nicholas, Villanueva, Gemma, Moro, Elena, Deuschl, Günther, Antonini, Angelo, Costa, João, Śmiłowska, Katarzyna, Berg, Daniela, Corvol, Jean Christophe, Fabbrini, Giovanni, Ferreira, Joaquim, Foltynie, Tom, Mir, Pablo, Schrag, Anette-Eleonore, Seppi, Klaus, Taba, Pille, Ruzicka, Evzen, Selikhova, Marianna, Henschke, Nicholas, Villanueva, Gemma, and Moro, Elena

Published
2022

114. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

Author

European Academy of Neurology, Christian-Albrechts-University Kiel, Projekt DEAL, Deuschl, Günther, Antonini, Angelo, Costa, João, Śmiłowska, Katarzyna, Berg, Daniela, Corvol, Jean Christophe, Fabbrini, Giovanni, Ferreira, Joaquim, Foltynie, Tom, Mir, Pablo, Schrag, Anette-Eleonore, Seppi, Klaus, Taba, Pille, Ruzicka, Evzen, Selikhova, Marianna, Henschke, Nicholas, Villanueva, Gemma, Moro, Elena, European Academy of Neurology, Christian-Albrechts-University Kiel, Projekt DEAL, Deuschl, Günther, Antonini, Angelo, Costa, João, Śmiłowska, Katarzyna, Berg, Daniela, Corvol, Jean Christophe, Fabbrini, Giovanni, Ferreira, Joaquim, Foltynie, Tom, Mir, Pablo, Schrag, Anette-Eleonore, Seppi, Klaus, Taba, Pille, Ruzicka, Evzen, Selikhova, Marianna, Henschke, Nicholas, Villanueva, Gemma, and Moro, Elena

Abstract

[Background and Purpose] This update of the treatment guidelines was commissioned by the European Academy of Neurology and the European section of the Movement Disorder Society. Although these treatments are initiated usually in specialized centers, the general neurologist should know the therapies and their place in the treatment pathway., [Methods] Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was used to assess the spectrum of approved interventions including deep brain stimulation (DBS) or brain lesioning with different techniques (radiofrequency thermocoagulation, radiosurgery, magnetic resonance imaging–guided focused ultrasound surgery [MRgFUS] of the following targets: subthalamic nucleus [STN], ventrolateral thalamus, and pallidum internum [GPi]). Continuous delivery of medication subcutaneously (apomorphine pump) or through percutaneous ileostomy (intrajejunal levodopa/carbidopa pump [LCIG]) was also included. Changes in motor features, health-related quality of life (QoL), adverse effects, and further outcome parameters were evaluated. Recommendations were based on high-class evidence and graded in three gradations. If only lower class evidence was available but the topic was felt to be of high importance, clinical consensus of the guideline task force was gathered., [Results] Two research questions have been answered with eight recommendations and five clinical consensus statements. Invasive therapies are reserved for specific patient groups and clinical situations mostly in the advanced stage of Parkinson's disease (PD). Interventions may be considered only for special patient profiles, which are mentioned in the text. Therapy effects are reported as change compared with current medical treatment. STN-DBS is the best-studied intervention for advanced PD with fluctuations not satisfactorily controlled with oral medications; it improves motor symptoms and QoL, and treatment should be offered to eligible patients. GPi-DBS can also be offered. For early PD with early fluctuations, STN-DBS is likely to improve motor symptoms, and QoL and can be offered. DBS should not be offered to people with early PD without fluctuations. LCIG and an apomorphine pump can be considered for advanced PD with fluctuations not sufficiently managed with oral treatments. Unilateral MRgFUS of the STN can be considered for distinctly unilateral PD within registries. Clinical consensus was reached for the following statements: Radiosurgery with gamma radiation cannot be recommended, unilateral radiofrequency thermocoagulation of the pallidum for advanced PD with treatment-resistant fluctuations and unilateral radiofrequency thermocoagulation of the thalamus for resistant tremor can be recommended if other options are not available, unilateral MRgFUS of the thalamus for medication-resistant tremor of PD can be considered only within registries, and unilateral MRgFUS of the pallidum is not recommended., [Conclusions] Evidence for invasive therapies in PD is heterogeneous. Only some of these therapies have a strong scientific basis. They differ in their profile of effects and have been tested only for specific patient groups. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Published
2022

115. Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study

Author

European Commission, Schrag, Anette-Eleonore, Martino, Davide, Wang, Hanyuying, Ambler, Gareth, Benaroya-Milstein, Noa, Buttiglione, Maura, Cardona, Francesco, Creti, Roberta, Efstratiou, Androulla, Hedderly, Tammy, Heyman, Isobel, Huyser, Chaim, Mir, Pablo, Morer, Astrid, Moll, Natalie, Müller, Norbert, Müller-Vahl, Kirsten R., Plessen, Kerstin J., Porcelli, Cesare, Rizzo, Renata, Roessner, Veit, Schwarz, Markus, Tarnok, Zsanett, Walitza, Susanne, Dietrich, Andrea, Hoekstra, Pieter J., European Commission, Schrag, Anette-Eleonore, Martino, Davide, Wang, Hanyuying, Ambler, Gareth, Benaroya-Milstein, Noa, Buttiglione, Maura, Cardona, Francesco, Creti, Roberta, Efstratiou, Androulla, Hedderly, Tammy, Heyman, Isobel, Huyser, Chaim, Mir, Pablo, Morer, Astrid, Moll, Natalie, Müller, Norbert, Müller-Vahl, Kirsten R., Plessen, Kerstin J., Porcelli, Cesare, Rizzo, Renata, Roessner, Veit, Schwarz, Markus, Tarnok, Zsanett, Walitza, Susanne, Dietrich, Andrea, and Hoekstra, Pieter J.

Abstract

[Background and Objectives] The goal of this work was to investigate the association between group A streptococcal (GAS) infections and tic incidence among unaffected children with a family history of chronic tic disorders (CTDs)., [Methods] In a prospective cohort study, children with no history for tics who were 3 to 10 years of age with a first-degree relative with a CTD were recruited from the European Multicentre Tics in Children Study (EMTICS) across 16 European centers. Presence of GAS infection was assessed with throat swabs, serum anti–streptolysin O titers, and anti-DNAse titers blinded to clinical status. GAS exposure was defined with 4 different definitions based on these parameters. Cox regression analyses with time-varying GAS exposure were conducted to examine the association of onset of tics and GAS exposure during follow-up. Sensitivity analyses were conducted with Cox regression and logistic regression analyses., [Results] A total of 259 children were recruited; 1 child was found to have tic onset before study entry and therefore was excluded. Sixty-one children (23.6%) developed tics over an average follow-up period of 1 (SD 0.7) year. There was a strong association of sex and onset of tics, with girls having an ≈60% lower risk of developing tics compared to boys (hazard ratio [HR] 0.4, 95% confidence interval [CI] 0.2–0.7). However, there was no statistical evidence to suggest an association of any of the 4 GAS exposure definitions with tic onset (GAS exposure definition 1: HR 0.310, 95% CI 0.037–2.590; definition 2: HR 0.561, 95% CI 0.219–1.436; definition 3: HR 0.853, 95% CI 0.466–1.561; definition 4: HR 0.725, 95% CI 0.384–1.370)., [Discussion] These results do not suggest an association between GAS exposure and development of tics.

Published
2022

116. Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study

Author

Schrag, Anette Eleonore, Martino, Davide, Wang, Hanyuying, et al, Walitza, Susanne; https://orcid.org/0000-0002-8161-8683, Schrag, Anette Eleonore, Martino, Davide, Wang, Hanyuying, et al, and Walitza, Susanne; https://orcid.org/0000-0002-8161-8683

Abstract

ObjectiveTo investigate the association between Group-A streptococcal (GAS) infections and tic incidence among unaffected children with a family history of chronic tic disorders (CTD).MethodsIn a prospective cohort study, children with no history for tics aged 3 to 10 years with a first-degree relative with CTD were recruited from the European Multicentre Tics in Children Study (EMTICS) across 16 European centres. Presence of GAS infection was assessed using throat swabs, serum Anti-streptolysin O titres (ASOT) and Anti-DNAse B (ADB) titres blinded to clinical status. GAS exposure was defined using four different definitions based on these parameters. Cox regression analyses with time-varying GAS exposure were conducted to examine the association of onset of tics and GAS exposure during follow-up. Sensitivity analyses were conducted using Cox regression and logistic regression analyses.ResultsA total of 260 children were recruited whilst one subject was found to have tic onsets before study entry and therefore was excluded. 61 children (23.6%) developed tics over an average follow-up period of 1 (SD 0.7) year. There was a strong association of sex and onset of tics, with girls having an approximately 60% lower risk of developing tics compared to boys (HR: 0.4, 95% CI 0.2-0.7). However, there was no statistical evidence to suggest an association of any of the four GAS exposure definitions with tic onset (GAS exposure definition 1: HR=0.310, 95% CI: 0.037-2.590; definition 2: HR=0.561, 95% CI: 0.219-1.436; definition 3: HR=0.853, 95% CI: 0.466-1.561; definition 4: HR=0.725, 95% CI: 0.384-1.370).ConclusionThese results do not suggest an association of GAS exposure and development of tics.Classification of EvidenceThis study provides Class I evidence that Group-A streptococcal exposure does not associate with the development of tics in children with first-degree relatives with chronic tic disorder.

Published
2022

122. Scales for Antipsychotic‐Associated Movement Disorders: Systematic Review, Critique, and Recommendations.

Author

Martino, Davide, Karnik, Vikram, Bhidayasiri, Roongroj, Hall, Deborah A., Hauser, Robert A., Macerollo, Antonella, Pringsheim, Tamara M., Truong, Daniel, Factor, Stewart A., Skorvanek, Matej, Schrag, Anette, Tosin, Michelle H. S., Shukla, Aparna Wagle, Espay, Alberto, Wu, Ruey‐Meei, Kovacs, Norbert, Meissner, Wassilios, Kleiner, Galit, Markaki, Ioanna, and Weintraub, Daniel

Abstract

Background: Antipsychotic‐associated movement disorders remain common and disabling. Their screening and assessment are challenging due to clinical heterogeneity and different use of nomenclature between psychiatrists and neurologists. Objective: An International Parkinson and Movement Disorder Society subcommittee aimed to rate psychometric quality of severity and screening instruments for antipsychotic‐associated movement disorders. Methods: Following the methodology adopted by previous International Parkinson and Movement Disorders Society subcommittee papers, instruments for antipsychotic‐associated movement disorders were reviewed, applying a classification as "recommended," "recommended with caveats," "suggested," or "listed." Results: Our review identified 23 instruments. The highest grade of recommendation reached is "recommended with caveats," assigned to seven severity rating instruments (Extrapyramidal Symptoms Rating Scale, Barnes Akathisia Rating Scale, Abnormal Involuntary Movements Scale, Drug‐Induced Extra‐Pyramidal Symptoms Scale, Maryland Psychiatric Research Centre involuntary movements scale, Simpson Angus Scale, and Matson Evaluation of Drug Side effects). Only three of these seven (Drug‐Induced Extra‐Pyramidal Symptoms Scale, Maryland Psychiatric Research Centre, Matson Evaluation of Drug Side effects) were also screening instruments. Their main caveats are insufficient demonstration of psychometric properties (internal consistency, skewing, responsiveness to change) and long duration of administration. Eight "suggested" instruments did not meet requirements for the "recommended" grade also because of insufficient psychometric validation. Other limitations shared by several instruments are lack of comprehensiveness in assessing the spectrum of antipsychotic‐associated movement disorders and ambiguous nomenclature. Conclusions: The high number of instruments "recommended with caveats" does not support the need for developing new instruments for antipsychotic‐associated movement disorders. However, addressing the caveats with new psychometric studies and revising existing instruments to improve the clarity of their nomenclature are recommended next steps. © 2023 International Parkinson and Movement Disorder Society. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

123. The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson's Disease.

Author

Ramadhan, Mouhammed and Schrag, Anette

Subjects
*PARKINSON'S disease, *QUALITY of life, *BURDEN of care, *DEMENTIA patients, *COGNITIVE ability
Abstract

Objective: To examine the validity of health-related quality of life (Hr-QoL) measures in patients with late-stage Parkinson's disease (PD). Methods: We analysed data from patients with late-stage PD and their carers who were assessed with a range of clinical measures and the EQ-5D-3 L. The DEMQOL-Proxy was completed for 157 patients with a diagnosis of dementia and the PDQ-8 by 401 patients without dementia. Convergent validity was assessed using correlations with measures of Parkinson's severity, independence and cognitive function, and construct validity using correlations with patients' own EQ-5D-3 L scores. In addition, we assessed divergent validity using correlations with carers' own EQ-5D index, EQ-VAS and Zarit caregiver burden scores. Results: In patients without dementia, both the PDQ-8 and EQ-5D-3 L correlated with measures of disease severity, dependence and carer burden scores, and PDQ-8 scores moderately with EQ-5D-3 L and EQ-5D-3 L VAS scores. In patients with dementia, EQ-5D-3 L scores correlated with disease severity, cognition and dependence scores, but DEMQOL-Proxy scores were moderately associated only with patients' dependence and carers' own EQ-5D-3 L scores but not patients' disease severity, EQ-5D-3 L or cognitive scores. Conclusions: The PDQ-8 and EQ-5D-3 L have adequate validity in late stage PD without dementia, but in those with PD and dementia the EQ-5D-3 L may be preferable to the DEMQOL-Proxy. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

134. Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population

Author

Simonet, Cristina, primary, Bestwick, Jonathan, additional, Jitlal, Mark, additional, Waters, Sheena, additional, Ben-Joseph, Aaron, additional, Marshall, Charles R., additional, Dobson, Ruth, additional, Marrium, Soha, additional, Robson, John, additional, Jacobs, Benjamin M., additional, Belete, Daniel, additional, Lees, Andrew J., additional, Giovannoni, Gavin, additional, Cuzick, Jack, additional, Schrag, Anette, additional, and Noyce, Alastair J., additional

Published
2022
Full Text
View/download PDF

135. Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study

Author

Schrag, Anette-Eleonore, Martino, Davide, Wang, Hanyuying, Ambler, Gareth, Benaroya-Milstein, Noa, Buttiglione, Maura, Cardona, Francesco, Creti, Roberta, Efstratiou, Androulla, Hedderly, Tammy, Heyman, Isobel, Huyser, Chaim, Mir, Pablo, Morer, Astrid, Moll, Natalie, Müller, Norbert E, Müller-Vahl, Kirsten R, Plessen, Kerstin J, Porcelli, Cesare, Rizzo, Renata, Roessner, Veit, Schwarz, Markus, Tarnok, Zsanett, Walitza, Susanne, Dietrich, Andrea, Hoekstra, Pieter J, European Multicentre Tics in Children Study (EMTICS), Clinical Cognitive Neuropsychiatry Research Program (CCNP), and European Commission

Subjects
Male, Incidence, Streptococcal Infections, Tic Disorders, Tics, Humans, Female, Neurology (clinical), Prospective Studies, Child
Abstract

[Background and Objectives] The goal of this work was to investigate the association between group A streptococcal (GAS) infections and tic incidence among unaffected children with a family history of chronic tic disorders (CTDs)., [Methods] In a prospective cohort study, children with no history for tics who were 3 to 10 years of age with a first-degree relative with a CTD were recruited from the European Multicentre Tics in Children Study (EMTICS) across 16 European centers. Presence of GAS infection was assessed with throat swabs, serum anti–streptolysin O titers, and anti-DNAse titers blinded to clinical status. GAS exposure was defined with 4 different definitions based on these parameters. Cox regression analyses with time-varying GAS exposure were conducted to examine the association of onset of tics and GAS exposure during follow-up. Sensitivity analyses were conducted with Cox regression and logistic regression analyses., [Results] A total of 259 children were recruited; 1 child was found to have tic onset before study entry and therefore was excluded. Sixty-one children (23.6%) developed tics over an average follow-up period of 1 (SD 0.7) year. There was a strong association of sex and onset of tics, with girls having an ≈60% lower risk of developing tics compared to boys (hazard ratio [HR] 0.4, 95% confidence interval [CI] 0.2–0.7). However, there was no statistical evidence to suggest an association of any of the 4 GAS exposure definitions with tic onset (GAS exposure definition 1: HR 0.310, 95% CI 0.037–2.590; definition 2: HR 0.561, 95% CI 0.219–1.436; definition 3: HR 0.853, 95% CI 0.466–1.561; definition 4: HR 0.725, 95% CI 0.384–1.370)., [Discussion] These results do not suggest an association between GAS exposure and development of tics., This project has received funding from the European Union’s Seventh Framework Program for research and technological development under grant agreement No. 278367.

Published
2022

136. sj-docx-2-ctj-10.1177_17407745221118555 – Supplemental material for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures

Author

Rookes, Tasmin A, Schrag, Anette, Walters, Kate, and Armstrong, Megan

Subjects
FOS: Clinical medicine, 160807 Sociological Methodology and Research Methods, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, FOS: Sociology
Abstract

Supplemental material, sj-docx-2-ctj-10.1177_17407745221118555 for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures by Tasmin A Rookes, Anette Schrag, Kate Walters and Megan Armstrong in Clinical Trials

Published
2022
Full Text
View/download PDF

137. Supplemental Material, tables_carer_paper_jgpn_suppl - Caregiver Burden in Late-Stage Parkinsonism and Its Associations

Author

Kalampokini, Stefania, Hommel, Adrianus L. A. J., Lorenzl, Stefan, Ferreira, Joaquim J., Meissner, Wassilios G., Odin, Per, Bloem, Bastiaan R., Dodel, Richard, and Schrag, Anette-Eleonore

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 110308 Geriatrics and Gerontology, 110904 Neurology and Neuromuscular Diseases, Neuroscience
Abstract

Supplemental Material, tables_carer_paper_jgpn_suppl for Caregiver Burden in Late-Stage Parkinsonism and Its Associations by Stefania Kalampokini, Adrianus L. A. J. Hommel, Stefan Lorenzl, Joaquim J. Ferreira, Wassilios G. Meissner, Per Odin, Bastiaan R. Bloem, Richard Dodel, Anette-Eleonore Schrag and the CLaSP consortium in Journal of Geriatric Psychiatry and Neurology

Published
2022
Full Text
View/download PDF

138. Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease

Author

Rosqvist, Kristina, Schrag, Anette, and Odin, Per

Subjects
caregiver burden, late stage, informal caregiver, Parkinson’s disease, humanities, Article
Abstract

Parkinson’s disease (PD) is a chronic, progressive, neurodegenerative disease involving both motor and non-motor symptoms (NMS). In the late stage of the disease, Hoehn and Yahr (HY) stages IV-V, the symptomatology is often severe and patients become increasingly dependent on help in their daily life, resulting in an increased burden for the informal caregivers. To assess the implications of the caregiver burden, caregiver quality of life (QoL) was assessed in 74 informal caregivers to patients in late stage PD, by the Alzheimer’s Patient Partners Life Impact Questionnaire (APPLIQue), which has been found useful also in PD. The majority of caregivers were the spouse/partner. Individual items provided information on which aspects of caregiver burden were the most common, i.e., items: “feel guilty if not there” (71% affirmed), “situation wears me down” (65% affirmed) and “always on my mind” (61% affirmed). In simple linear regression analyses, female patient gender (p = 0.007), better cognition (p = 0.004), lower NMS burden (p = 0.012) and not being the partner (p = 0.022) were associated with better caregiver QoL. Multivariable linear regression analyses identified better cognition (p = 0.004) and female patient gender (p = 0.035) as independently associated with better informal caregiver QoL. Identifying and treating NMS as well as recognizing and alleviating caregiver burden seem essential to enhance QoL for both patients and caregivers in late stage PD.

Published
2022

139. sj-docx-3-ctj-10.1177_17407745221118555 – Supplemental material for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures

Author

Rookes, Tasmin A, Schrag, Anette, Walters, Kate, and Armstrong, Megan

Subjects
FOS: Clinical medicine, 160807 Sociological Methodology and Research Methods, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, FOS: Sociology
Abstract

Supplemental material, sj-docx-3-ctj-10.1177_17407745221118555 for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures by Tasmin A Rookes, Anette Schrag, Kate Walters and Megan Armstrong in Clinical Trials

Published
2022
Full Text
View/download PDF

143. sj-docx-1-ctj-10.1177_17407745221118555 – Supplemental material for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures

Author

Rookes, Tasmin A, Schrag, Anette, Walters, Kate, and Armstrong, Megan

Subjects
FOS: Clinical medicine, 160807 Sociological Methodology and Research Methods, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, FOS: Sociology
Abstract

Supplemental material, sj-docx-1-ctj-10.1177_17407745221118555 for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures by Tasmin A Rookes, Anette Schrag, Kate Walters and Megan Armstrong in Clinical Trials

Published
2022
Full Text
View/download PDF

144. sj-docx-4-ctj-10.1177_17407745221118555 – Supplemental material for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures

Author

Rookes, Tasmin A, Schrag, Anette, Walters, Kate, and Armstrong, Megan

Subjects
FOS: Clinical medicine, 160807 Sociological Methodology and Research Methods, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, FOS: Sociology
Abstract

Supplemental material, sj-docx-4-ctj-10.1177_17407745221118555 for Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures by Tasmin A Rookes, Anette Schrag, Kate Walters and Megan Armstrong in Clinical Trials

Published
2022
Full Text
View/download PDF

149. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

Author

Ibañez, Kristina, primary, Polke, James, additional, Hagelstrom, R Tanner, additional, Dolzhenko, Egor, additional, Pasko, Dorota, additional, Thomas, Ellen Rachel Amy, additional, Daugherty, Louise C, additional, Kasperaviciute, Dalia, additional, Smith, Katherine R, additional, Deans, Zandra C, additional, Hill, Sue, additional, Fowler, Tom, additional, Scott, Richard H, additional, Hardy, John, additional, Chinnery, Patrick F, additional, Houlden, Henry, additional, Rendon, Augusto, additional, Caulfield, Mark J, additional, Eberle, Michael A, additional, Taft, Ryan J, additional, Tucci, Arianna, additional, McDonagh, Ellen M, additional, Rueda, Antonio, additional, Polychronopoulos, Dimitris, additional, Chan, Georgia, additional, Angus-Leppan, Heather, additional, Bhatia, Kailash P, additional, Davison, James E, additional, Festenstein, Richard, additional, Fratta, Pietro, additional, Giunti, Paola, additional, Howard, Robin, additional, Venkata, Laxmi, additional, Laurá, Matilde, additional, McEntagart, Meriel, additional, Menzies, Lara, additional, Morris, Huw, additional, Reilly, Mary M, additional, Robinson, Robert, additional, Rosser, Elisabeth, additional, Faravelli, Francesca, additional, Schrag, Anette, additional, Schott, Jonathan M, additional, Warner, Thomas T, additional, Wood, Nicholas W, additional, Bourn, David, additional, Eggleton, Kelly, additional, Labrum, Robyn, additional, Twiss, Philip, additional, Abbs, Stephen, additional, Santos, Liana, additional, Almheiri, Ghareesa, additional, Sheikh, Isabella, additional, Vandrovcova, Jana, additional, Patch, Christine, additional, Taylor Tavares, Ana Lisa, additional, Hyder, Zerin, additional, Need, Anna, additional, Brittain, Helen, additional, Baple, Emma, additional, Moutsianas, Loukas, additional, Deshpande, Viraj, additional, Perry, Denise L, additional, Ajay, Subramanian S., additional, Chawla, Aditi, additional, Rajan, Vani, additional, Oprych, Kathryn, additional, Douglas, Angela, additional, Wilson, Gill, additional, Ellard, Sian, additional, Temple, I Karen, additional, Mumford, Andrew, additional, McMullan, Dom, additional, Naresh, Kikkeri, additional, Flinter, Frances A, additional, Taylor, Jenny C, additional, Greenhalgh, Lynn, additional, Newman, William, additional, Brennan, Paul, additional, Sayer, John A, additional, Raymond, F Lucy, additional, Chitty, Lyn S, additional, Ambrose, John C., additional, Arumugam, Prabhu, additional, Bleda, Marta, additional, Boardman-Pretty, Freya, additional, Boissiere, Jeanne M., additional, Boustred, Christopher R., additional, Craig, Clare E.H., additional, de Burca, Anna, additional, Devereau, Andrew, additional, Elgar, Greg, additional, Foulger, Rebecca E., additional, Furió-Tarí, Pedro, additional, Hackett, Joanne, additional, Halai, Dina, additional, Hamblin, Angela, additional, Henderson, Shirley, additional, Holman, James, additional, Hubbard, Tim J.P., additional, Jackson, Rob, additional, Jones, Louise J., additional, Kayikci, Melis, additional, Lahnstein, Lea, additional, Lawson, Kay, additional, Leigh, Sarah E.A., additional, Leong, Ivonne U.S., additional, Lopez, Javier F., additional, Maleady-Crowe, Fiona, additional, Mason, Joanne, additional, Mueller, Michael, additional, Murugaesu, Nirupa, additional, Odhams, Chris A., additional, Perez-Gil, Daniel, additional, Pullinger, John, additional, Rahim, Tahrima, additional, Riesgo-Ferreiro, Pablo, additional, Rogers, Tim, additional, Ryten, Mina, additional, Savage, Kevin, additional, Sawant, Kushmita, additional, Siddiq, Afshan, additional, Sieghart, Alexander, additional, Smedley, Damian, additional, Sosinsky, Alona, additional, Spooner, William, additional, Stevens, Helen E., additional, Stuckey, Alexander, additional, Sultana, Razvan, additional, Thompson, Simon R., additional, Tregidgo, Carolyn, additional, Walsh, Emma, additional, Watters, Sarah A., additional, Welland, Matthew J., additional, Williams, Eleanor, additional, Witkowska, Katarzyna, additional, Wood, Suzanne M., additional, and Zarowiecki, Magdalena, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results